Etiopathogenic and Clinical Aspects in Inflammatory Bowel Disease – Literature Review

1. Zhao J, Lu Q, Liu Y, et al. Th17 Cells in Inflammatory Bowel Disease: Cytokines, Plasticity, and Therapies. Journal of Immunology Research. 2021;1-14.10.1155/2021/8816041784640433553436Search in Google Scholar

2. Jang HJ, Kang B, Choe BH. The difference in extraintestinal manifestations of inflammatory bowel disease for children and adults. Transl Pediatr. 2019;8:4-15.10.21037/tp.2019.01.06638250130881893Search in Google Scholar

3. Martinez-Fierro ML, Garza-Veloz I, Rocha-Pizaña MR, et al. Serum cytokine, chemokine, and growth factor profiles and their modulation in inflammatory bowel disease. Medicine (Baltimore). 2019;98:e17208.10.1097/MD.0000000000017208675669031567972Search in Google Scholar

4. Kim JM, Cheon JH. Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases. Intest Res. 2020;18:249-264.10.5217/ir.2019.00128738558132295331Search in Google Scholar

5. Ma C, Vasu R, Zhang H. The Role of Long-Chain Fatty Acids in Inflammatory Bowel Disease. Mediators Inflamm. 2019;2019: 8495913.10.1155/2019/8495913687487631780872Search in Google Scholar

6. Malaty HM, Lo GH, Hou JK. Characterization and prevalence of spondyloarthritis and peripheral arthritis among patients with inflammatory bowel disease. Clin Exp Gastroenterol. 2017;10:259-263.10.2147/CEG.S136383562773629026327Search in Google Scholar

7. Chams S, Badran R, Sayegh SE, Chams N, Shams A, Hajj Hussein I. Inflammatory bowel disease: Looking beyond the tract. Int J Immunopathol Pharmacol. 2019;33:1-18.10.1177/2058738419866567668511331382828Search in Google Scholar

8. Kotze LM, Costa CT, Cavassani MF, Nisihara RM. Alert for bone alterations and low serum concentrations of vitamin D in patients with intestinal inflammatory disease. Rev Assoc Med Bras. 2017;63:13-17.10.1590/1806-9282.63.01.1328225873Search in Google Scholar

9. Ungureanu L, Cosgarea R, Alexandru Badea M, et al. Cutaneous manifestations in inflammatory bowel disease (Review). Exp Ther Med. 2020;20:31-37.Search in Google Scholar

10. Antonelli E, Bassotti G, Tramontana M, et al. Dermatological Manifestations in Inflammatory Bowel Diseases. J Clin Med. 2021;10;1-16.10.3390/jcm10020364783597433477990Search in Google Scholar

11. Lauritano D, Boccalari E, Di Stasio D, et al. Prevalence of Oral Lesions and Correlation with Intestinal Symptoms of Inflammatory Bowel Disease: A Systematic Review. Diagnostics (Basel). 2019;9:1-16.10.3390/diagnostics9030077678770431311171Search in Google Scholar

12. Kumar KM, Nachiammai N, Madhushankari GS. Association of oral manifestations in ulcerative colitis: A pilot study. J Oral Maxillofac Pathol. 2018;22:199-203.10.4103/jomfp.JOMFP_223_16609737330158772Search in Google Scholar

13. Troncoso LL, Biancardi AL, de Moraes HV Jr, Zaltman C. Ophthalmic manifestations in patients with inflammatory bowel disease: a review. World J Gastroenterol. 2017;23:5836-5848.10.3748/wjg.v23.i32.5836558356928932076Search in Google Scholar

14. Silva J, Brito BS, de N. Silva IN, et al. Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients. Biomed Res Int. 2019;2019:7604939.10.1155/2019/7604939637487830834274Search in Google Scholar

15. de Vries AB, Janse M, Blokzijl H, Weersma RK. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol. 2015;21:1956-1971.10.3748/wjg.v21.i6.1956432347625684965Search in Google Scholar

16. Fousekis FS, Theopistos VI, Katsanos KH, et al. Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review. Gastroenterol Res. 2018;11:83-94.10.14740/gr990w591663129707074Search in Google Scholar

17. Iida T, Wagatsuma K, Hirayama D, Yokoyama Y, Nakase H. The Etiology of Pancreatic Manifestations in Patients with Inflammatory Bowel Disease. J Clin Med. 2019;8:916.10.3390/jcm8070916667903631247968Search in Google Scholar

18. Fousekis FS, Theopistos VI, Katsanos KH, Christodoulou DK. Pancreatic Involvement in Inflammatory Bowel Disease: A Review. J Clin Med Res. 2018;10:743-751.10.14740/jocmr3561w613500330214645Search in Google Scholar

19. Kacprzak A, Szturmowicz M, Kus J. Respiratory system involvement in inflammatory bowel diseases. Adv Respir Med. 2017;85:161-168.10.5603/ARM.2017.002828667659Search in Google Scholar

20. Ji XQ, Wang LX, Lu DG. Pulmonary manifestations of inflammatory bowel disease. World J Gastroenterol. 2014;20:13501-13511.10.3748/wjg.v20.i37.13501418890125309080Search in Google Scholar

21. Xu L, Xiao W, Ma D, Zhou S, Zhang Q. Ulcerative colitis combined with acute interstitial lung disease and airway disease: A case report and literature review. Exp Ther Med. 2014;8:1229-1236.10.3892/etm.2014.1895415178225187830Search in Google Scholar

22. Bunu DM, Timofte CE, Ciocoiu M, et al. Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies. Gastroenterol Res Pract. 2019;2019:3012509.10.1155/2019/3012509634881830733802Search in Google Scholar

23. Harbord M, Annese V, Vavricka SR, et al. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. J Crohns Colitis. 2016;10:239-254.10.1093/ecco-jcc/jjv213495747626614685Search in Google Scholar

24. Mitchell NE, Harrison N, Junga Z, Singla M. Heart Under Attack: Cardiac Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018;24:2322-2326.10.1093/ibd/izy15729788235Search in Google Scholar

25. Ali SA, Abbasi Z, Shahid B, et al. The prevalence, characteristics, and determinants of anaemia in newly diagnosed patients with inflammatory bowel disease. Gastroenterology Rev. 2019;14:39-47.10.5114/pg.2019.83424644410430944676Search in Google Scholar

26. Tulewicz-Marti E, Moniuszko A, Rydzewska G. Management of anemia in inflammatory bowel disease: a challenge in everyday clinical practice. Gastroenterol Rev. 2017;12:239-243.10.5114/pg.2017.72096577144629358991Search in Google Scholar

27. Nemes RM, Pop CS, Calagiu D, et al. Anemia in inflammatory bowel disease more than an extraintestinal complication. Rev Med Chir. 2016;120:34-39.Search in Google Scholar

28. Epistola R, Do T, Vankina R, et al. Immune thrombocytopenic purpura (ITP) as an uncommon extraintestinal complication of Crohn’s disease: case vignette and systematic literature review. Case Rep Hematol. 2020;2020:4785759.10.1155/2020/4785759713677032274225Search in Google Scholar

29. Jimenez K, Kulnigg-Dabsch S, Gasche C. Management of Iron Deficiency Anemia. Gastroenterol Hepatol (N Y). 2015;11:241-250.Search in Google Scholar

30. Fagagnini S, Heinrich H, Rossel JB, et al. Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases. PLoS ONE. 2017;12:e0185193.10.1371/journal.pone.0185193563823529023532Search in Google Scholar

31. Pittet V, Juillerat P, Mottet C, et al. Cohort Profile: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). Int J Epidemiol. 2009;38:922-931.10.1093/ije/dyn18018782896Search in Google Scholar

32. Li M, Yang QF, Cao Q, et al. High-risk human papilloma virus infection and cervical neoplasm in female inflammatory bowel disease patients: a cross-sectional study. Gastroenterol Rep (Oxf). 2019;7:338-344.10.1093/gastro/goy053682121931687153Search in Google Scholar

33. Kuźnicki P, Kempiński R, Neubauer K. The emerging role of mood disorders in inflammatory bowel diseases. Adv Clin Exp Med. 2020;29:1505-1510.10.17219/acem/12767633389842Search in Google Scholar

34. Davis SP, Bolin LP, Crane PB, Crandell J. Non-pharmacological Interventions for Anxiety and Depression in Adults With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Front Psychol. 2020;11:538741.10.3389/fpsyg.2020.538741767629333250803Search in Google Scholar

35. Singh S, Kumar N, Loftus EV Jr, Kane SV. Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologics. Inflamm Bowel Dis. 2013;19:864-872.10.1002/ibd.2301122552994Search in Google Scholar

36. Ott C, Schölmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol. 2013;10:585-595.10.1038/nrgastro.2013.11723835489Search in Google Scholar